Parametric Portfolio Associates’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-69,935
| Closed | -$808K | – | 3989 |
|
|
2020
Q2 | $808K | Buy |
+69,935
| New | +$808K | ﹤0.01% | 3034 |
|
|
2019
Q4 | – | Sell |
-4,071
| Closed | -$22K | – | 4012 |
|
|
2019
Q3 | $22K | Sell |
4,071
-5,714
| -58% | -$30.9K | ﹤0.01% | 3926 |
|
|
2019
Q2 | $75K | Buy |
9,785
+5,367
| +121% | +$41.1K | ﹤0.01% | 3874 |
|
|
2019
Q1 | $88K | Buy |
4,418
+1,638
| +59% | +$32.6K | ﹤0.01% | 3833 |
|
|
2018
Q4 | $37K | Sell |
2,780
-4,627
| -62% | -$61.6K | ﹤0.01% | 3866 |
|
|
2018
Q3 | $272K | Sell |
7,407
-212
| -3% | -$7.79K | ﹤0.01% | 3648 |
|
|
2018
Q2 | $267K | Sell |
7,619
-4,560
| -37% | -$160K | ﹤0.01% | 3598 |
|
|
2018
Q1 | $566K | Buy |
12,179
+4,880
| +67% | +$227K | ﹤0.01% | 3279 |
|
|
2017
Q4 | $274K | Buy |
7,299
+1,953
| +37% | +$73.3K | ﹤0.01% | 3609 |
|
|
2017
Q3 | $285K | Sell |
5,346
-279
| -5% | -$14.9K | ﹤0.01% | 3695 |
|
|
2017
Q2 | $321K | Buy |
5,625
+2,540
| +82% | +$145K | ﹤0.01% | 3601 |
|
|
2017
Q1 | $166K | Buy |
3,085
+424
| +16% | +$22.8K | ﹤0.01% | 3629 |
|
|
2016
Q4 | $152K | Sell |
2,661
-806
| -23% | -$46K | ﹤0.01% | 3651 |
|
|
2016
Q3 | $215K | Buy |
3,467
+939
| +37% | +$58.2K | ﹤0.01% | 3553 |
|
|
2016
Q2 | $143K | Buy |
+2,528
| New | +$143K | ﹤0.01% | 3676 |
|